降低转氨酶的药物及其用法（Medicine for reducing transaminase and its use）

降低转氨酶的药物及其用法（Medicine for reducing transaminase and its use） 降低转氨酶的药物及其用法(Medicine for reducing transaminase and its use) Biphenyl diester Bifendate [pharmacology and application] this product can enhance the liver detoxification function, alleviate the pathological damage of the liver, promote the regeneration of liver cells and protect the liver cells, thereby improving the liver function. Have a certain effect on the main symptoms such as hepatitis, liver pain, fatigue, bloating and other improvements, but had no effect on the change of liver and spleen. For patients with prolonged hepatitis and chronic alanine aminotransferase abnormalities. [usage] oral dosage: 75 to 150mg per day, use 3 times a day, take 25mg every time. [note] adverse reactions are mild and mild nausea may occur in individual cases after taking this product. It has been reported that jaundice and exacerbations during the treatment of this product should be noticed. [preparation] drop pill: 1.5mg per pill. Silymarin Silibinin [application] pharmacological and this product has obvious protective effect and stability of liver cell membrane, has protective and therapeutic effects of different degree of various types of liver induced by CCl4 and thioacetamide, carnitine, Phalloidine, usaramine and other toxic liver injury, have certain effect to prevent elevated alanine aminotransferase and carbon tetrachloride transfer caused by enzyme. It is suitable for the treatment of chronic persistent hepatitis, chronic active hepatitis, primary liver cirrhosis, toxic liver injury and other diseases. [usage] orally: every 70 to 140mg, 3 times a day, after meals. Maintenance can be halved. [notice] less adverse reactions, dizziness, nausea, hiccups, mild diarrhea and so on. [preparation] tablets: 21mg per tablet. Bicyclic alcohol Bicyclol [pharmacology and application] this product has significant protective effect on liver and certain anti hepatitis B virus activity. The mechanism of action is not to inhibit the aminotransferase, but to scavenge the free radical to protect the cell membrane, and protect the liver cell nucleus DNA from injury and reduce the occurrence of apoptosis. Elevated aminotransferase levels used in the treatment of chronic hepatitis. [usage] oral dosage: 25mg per common dose, increase 50mg when necessary, 3 times a day. The course of treatment shall be taken at least 6 months or as prescribed by the doctor, and the withdrawal shall be gradually reduced. [note] this product is well tolerated. Individual patients can appear dizziness; very few patients have rash, rash obvious can stop drug observation, if necessary, can take anti allergy drugs. During the period of treatment, the clinical symptoms, signs and liver function changes should be closely observed, and follow-up should be strengthened after the course of treatment. Patients with hepatic decompensation, such as elevated bilirubin, hypoproteinemia, cirrhosis, ascites, esophageal varices bleeding, hepatic encephalopathy, and hepatorenal syndrome, should be used with caution. There is no data on the safety of medication for pregnant women, lactating women and elderly patients over 70 years of age. The optimal dose for children under 12 years of age is prescribed by doctors. [preparation] tablets: 25mg per tablet. Two glycyrrhizic acid amine Diammonium [Glycyrrhizinate] Potenline [pharmacology and application] this product has a strong anti-inflammatory, protective liver cells and improve liver function, this product also has anti allergy, inhibition of calcium influx and immune regulation. For chronic hepatitis with alanine aminotransferase elevation. [oral]: 150mg each time, 3 times a day, intravenous drip: 30ml, 10% glucose solution, 250ml diluted, intravenous drip, 1 times a day. [note] a few patients may have elevated blood pressure, dizziness, headache, epigastric discomfort, abdominal distension, skin rashes and fever, which generally do not affect treatment. During treatment, blood pressure and serum potassium and sodium concentrations should be measured regularly. If high blood pressure, sodium retention, and hypokalemia occur, the dosage should be reduced or stopped. [preparation] capsule: 50mg per granule. Injection: each 50mg (10ml). Glycyrrhizic acid, cysteine, Monoammonium, Glycyrrhizinate [pharmacology and application] the alpha alpha glycyrrhizin contained in this product inhibits the delta 4-5- beta reductase in the liver, thereby hindering the inactivation of cortisol and aldosterone; Moreover, the conformation of alpha glycyrrhizin is similar to that of steroid, and can be directly combined with the target cell receptor of steroid hormone. Cysteine hydrochloride can be converted into methionine in vivo and can synthesize choline and creatine in human body. Choline is a lipotropics treatment and protection of liver function caused by arsenic, barbiturates and other organic matter carbon tetrachloride toxic hepatitis, methionine. The utility model is suitable for chronic persistent hepatitis, chronic active hepatitis, acute hepatitis, liver poisoning, early hepatocirrhosis, and can also be used for allergic diseases. [usage] intravenous drip: once 100 ~ 250ml, slowly drip, 1 times a day. [attention] during treatment, blood pressure, serum potassium and sodium concentration should be monitored regularly. If high blood pressure, sodium retention and hypokalemia occur, withdrawal or appropriate reduction should be taken. Disable renal failure patients. [preparation] glycyrrhizin, cysteine, Sodium Chloride Injection: 250ML. Compound glycyrrhizin Compound Glycyrrhizin [pharmacology and application] glycyrrhizin can inhibit the liver cell injury caused by carbon tetrachloride. It is used for the abnormal liver function caused by acute or chronic hepatitis, so as to improve the abnormal liver function. [note] adverse reactions include nausea, vomiting, abdominal distension, and skin pruritus, urticaria, dry mouth and edema, headache, dizziness, palpitations and hypertension increased, generally lighter. Patients who have allergies to this product, patients with aldosterone, myopathy, and hypokalemia are prohibited. [usage] preparation and compound glycyrrhizin (Mei Neng): each 20ml containing glycyrrhizic acid single salt 53mg 400mg; glycine; cysteine hydrochloride 20mg. Intravenous injection, adult 1 times a day, 5 ~ 20ml. Chronic liver disease can be intravenous or intravenous drip, 1 times a day, 40 to 60ml, incremental dose limit of one day 100ml. Compound glycyrrhizin tablets (Mei Neng): each tablet contains monoammonium 35mg, glycine, 25mg, methionine, 25mg. Take orally 3 times a day, 2~3 adults, 1 children. Compound glycyrrhizin (Li Jun): each 20ml containing glycyrrhizic acid single salt 40.83mg 20mg 400mg cysteine hydrochloride; glycine. Intravenous injection, adult 1 times a day, 5 ~ 20ml. Chronic liver disease can be intravenous or intravenous drip, 1 times a day, 40 to 60ml, incremental dose limit of one day 100ml. Magnesium Magnesium Isoglycyrrhizinate [pharmacology and application] is a liver cell protective agent. It has the function of anti inflammation, protecting liver membrane and improving liver function. This product is suitable for chronic viral hepatitis. Improve abnormal liver function. [Methods] once a day, once 0.1g (2), be diluted with 10% Glucose Injection 250ml, and be treated for a course of treatment or as prescribed by the doctor. In case of illness, 0.2g (4 PCS) can be used daily. [note] patients with severe hypokalemia, hypernatremia, hypertension, heart failure, and renal failure are prohibited. Adverse reactions included pseudo aldosteronism, palpitations, eyelid edema, dizziness, skin rashes and vomiting. Pregnant women and lactating women and children are not recommended for use. [preparation] injection: every 10ml (50mg).